This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MetLife Prices Remarketing Of Series C Senior Component Debentures

MetLife, Inc. (NYSE: MET) announced today the pricing of its remarketing of $500 million aggregate principal amount of its 1.756% Series C Senior Component Debentures, Tranche 1 and $500 million aggregate principal amount of its 3.048% Series C Senior Component Debentures, Tranche 2. Both tranches originally comprised $1 billion aggregate principal amount of MetLife’s Series C Senior Debentures due 2023 and formed part of its 40 million common equity units, which were issued in November 2010 in connection with MetLife’s acquisition of American Life Insurance Company and Delaware American Life Insurance Company.

Following the settlement of the remarketing, effective October 10, 2012, the stated maturity of the Tranche 1 and Tranche 2 Debentures will be December 15, 2017 and December 15, 2022, respectively. Proceeds of the remarketing, net of the remarketing agents’ fees, will be paid to the holders of the common equity units, who will ultimately use $1 billion of those proceeds to purchase newly-issued shares of MetLife common stock from MetLife, Inc. under stock purchase contracts constituting part of the common equity units.

Deutsche Bank Securities, Credit Suisse, J.P. Morgan and Morgan Stanley acted as lead remarketing agents.

This press release is neither an offer to sell, nor a solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state. MetLife has filed a registration statement, including a prospectus supplement and the accompanying prospectus, with the Securities and Exchange Commission for the offering to which this press release relates. These documents can be accessed at no charge by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, these documents can be requested from Deutsche Bank Securities Inc., Attn.: Prospectus Group, 60 Wall Street, New York, NY 10005-2836, Email: prospectus.CPDG@db.com, Tel: (800) 503-4611; Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, Eleven Madison Avenue, New York, NY 10010; J.P. Morgan Securities LLC, 383 Madison Avenue, New York, NY 10179, Attn: Investment Grade Syndicate Desk - 3rd floor, Tel: (212) 834-4533; Morgan Stanley & Co. LLC, 180 Varick Street, New York, NY 10014, Attn: Prospectus Department.

MetLife, Inc. is a leading global provider of insurance, annuities and employee benefit programs, serving 90 million customers. Through its subsidiaries and affiliates, MetLife holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

This press release may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operations and financial results.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,154.41 +74.27 0.41%
S&P 500 2,124.15 +6.46 0.30%
NASDAQ 5,114.4320 +22.3470 0.44%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs